← All thesesBWXTUnattractiveMedium convictionMonday 2 November 2026עברית

BWX Technologies

This is the archived full research. Read the story

The company that builds every reactor and makes all the fuel for the US Navy's nuclear submarines and carriers, plus a smaller business making parts for power plants.

Our viewUnattractive Medium conviction
The scores
The profile · 1-4
Growth3/4 →

Revenue grew 18.3% in 2025, 18% in Q2 2026 (9% organic) and 10% in Q3 2026, and the naval half grew 2% then 4%.

Business quality3/4 →

The naval half is protected, the only two Category I plants, but the commercial third competes with Doosan and Framatome on price.

Financial position3/4 ↑

About $1.41B of net debt, roughly 2.1 times guided profit before depreciation, with notes due 2028 and 2029 to refinance.

Execution record4/4 →

Eight beats in eight quarters and the last Investor Day's targets exceeded: 15% yearly growth against mid-single digits promised.

Per share capture3/4 →

Shares flat at 92.0M and deals paid in cash, but buybacks stopped in 2026 and margins fell as acquisitions grew revenue.

Potential3/4 ↑

$8.4B of backlog and $3.1B of NNSA awards are committed; the commercial new-build wave is expected, not signed.

Risk profile3/4 →

One buyer, the US government, is 68% of revenue: disclosed, long-standing and survivable, but one budget decision moves it.

Valuation1/4 ↑

About 21.9 times operating profit before depreciation, 148% of a three-stage value near $80.93 at an 8% return: priced for perfection, beyond the 20% margin.

Evidence quality3/4 →

The moat, orders and price rest on filings, the NRC and CRS; the growth the price needs rests on management's plan.

The bet · 2-3 years
Safe, little upside0.9×

If it works 0.9× · if it fails you keep about 77%.

The Verdict

We rate BWX Technologies unattractive. Two thirds of it is protected: the only maker of the Navy's reactors and their fuel, paid at cost plus a steady fee, so the business is solid. The price is full: about right for two more years of its own plan, with no credit for its 2030 targets. As a bet on commercial power plants it is expensive and defensive: little lost if that stalls, little gained if it works. Our view would change if the naval half keeps growing profit while the commercial half signs its first new-reactor order.

The long caseNuclear costs a lot to build and little to run, gas the reverse; with turbines sold out, extending old reactors is the cheapest new power.

How we weighed it

The price against our value

Against it

Price at 148% of our value

The price sits above our value and above the bull case.

The business

In its favour

Solid

The only maker of the Navy's reactors, paid at cost plus a steady fee.

Growth against what the price assumes

Cuts both ways

The plan needs an unsigned new-build order and faster shipyards.

What could go wrong

Against it

The government is most of sales, shipyards set the pace and commercial orders are contested.

Against competitors

Cuts both ways

No filed rival compares directly; against its own normal it is still dearer.

How its group is behaving

Cuts both ways

Aerospace and defense names move together on budgets.

The latest news and report

Cuts both ways

The last report showed a naval profit jump but no new-reactor order.

The evidence under this - 7 claims
C31inferencemedium confidence
The naval half is a structural monopoly on volume but not on price: only BWXT's two plants may make the fuel, designs are classified, and the Navy has no other supplier, yet contracts bill allowable cost plus fee, so the shelter shows up as steady orders at about a 21% margin before depreciation.
derivedThe licences (C06), sole supply to every class (C07), the 10-K on limited competition and cost-based pricing (C08), and Q2 2026 segment margin (C03).
against this

Naval Reactors owns the designs, so the customer controls the technology and could in principle license a second maker; none is proposed (S01).

current state · 2026-06-30written 2026-10-05
C22inferencemedium confidence
At $13.77B of company value the price is about 20.6 times the $667M midpoint of 2026 adjusted EBITDA guidance, against BWXT's 16.9 median in prior years. At 16.9 times the price needs about $815M, a level the 2030 plan's straight line reaches between 2027 and 2028.
derivedCompany value (C21) over the guidance midpoint (C12); $1.15B in 2030 from $667M in 2026 is about 14.6% a year, giving about $764M in 2027 and $876M in 2028 (C11).
against this

The 16.9 norm was struck when the company grew 5% to 8% a year; on the 2030 target midpoint the same company value is about 12 times (C11).

forwardwritten 2026-10-05
C12management claimmedium confidence
On 2 November 2026 BWXT reaffirmed 2026 revenue of about $3.8B and tightened adjusted EBITDA to about $667M (from $662M to $672M), non-GAAP EPS to $4.72 to $4.77 (from $4.70 to $4.80) and free cash flow to $350M to $360M (from $345M to $360M). It introduced a preliminary 2027 outlook of high-single-digit revenue growth and high-single-digit to low-double-digit growth in adjusted EBITDA and EPS. The August split (Government Operations up high single digits, Commercial up about 45%) is not restated in the release.
against this

Government Operations revenue grew 2% in Q2 and 4% in Q3 2026 (C03), against the August guide of high-single-digit growth for the year.

  1. 2026-11-02editedQ3 release tightened the 2026 guide and gave a first 2027 outlook
forwardwritten 2026-10-05
C11management claimmedium confidence
At its 29 September 2026 Investor Day BWXT targeted 2030 revenue of $5.5B to $6B, adjusted EBITDA of $1.1B to $1.2B, free cash flow of $525M to $575M and over $2B of cumulative free cash flow from 2026 to 2030. It guided Government Operations to high single to low double-digit yearly revenue growth, with naval propulsion in mid single digits, and Commercial to high-teens revenue growth with its EBITDA margin rising from about 13% and EBITDA growing over 20% a year.
against this

Government Operations adjusted EBITDA fell in Q2 2026 (C03), and over half of Commercial's Q2 growth was acquired (C13).

forwardwritten 2026-10-05
C34estimatelow confidence
Commercial Operations without the medical business should earn about $145M of adjusted EBITDA in 2026, about 13% of the $1.1B of revenue management expects; at the Investor Day's 20% yearly growth that is about $210M in 2028.
derivedThe 13% segment margin guide (C12), management's $1.1B of 2026 commercial revenue without medical (S09) and its over-20% EBITDA growth target (C11).
against this

First-half commercial bookings fell 36% (C04), and the growth target assumes new-build orders not yet signed (C29).

forwardwritten 2026-10-05
C29management claimlow confidence
On the Q2 2026 call management said there is 'a credible opportunity to secure at least one new build nuclear equipment order before the year-end'; on the Q3 2026 call (2 November) the chief executive said a first order for US reactor plant builds by the end of 2026 'is a possibility', and 'certainly no later than about the first half of the next year', with small modular reactors (Darlington, then Tennessee Valley Authority) ahead of large reactors and the gate being how risk is shared rather than financing.
against this

Commercial bookings fell to $464.0M in the first half from $721.6M a year earlier (C04).

  1. 2026-11-03editedQ3 2026 call restated the timing: still possible by year-end but now 'no later than about the first half' of 2027; the order is not signed.
forwardwritten 2026-10-05
C03facthigh confidence
In Q3 2026 revenue was $953.0M, up 10%: Government Operations $639.1M, up 4%, and Commercial Operations $314.2M, up 25%. Government Operations adjusted EBITDA rose 22% to $144.2M from $118.3M and its operating income 26% to $122.6M from $97.4M; Commercial adjusted EBITDA rose 17% to $41.4M from $35.5M. Diluted EPS was $1.11 ($1.26 adjusted) and free cash flow $150.5M. In Q2 2026 Government Operations adjusted EBITDA had fallen to $126.5M from $133.0M.
  1. 2026-11-02editedQ3 2026 replaces Q2: the naval half's profit rose 22% after falling in Q2
historical · Q3 2026written 2026-10-05
01

The company

A nuclear submarine needs a reactor and enough fuel to run for decades. BWXT makes both. Its Lynchburg, Virginia plant builds the reactors and cores, and its Nuclear Fuel Services plant in Tennessee makes the fuel for every reactor the US Navy runs, from the Virginia-class submarines to the Ford-class carriers.

The other third of the company sells steam generators, reactor parts, fuel and repair services to power-plant owners. It is the only maker of heavy nuclear parts in North America, and most of its customers are Canadian utilities.

The evidence under this - 4 claims
C01facthigh confidence
BWXT has two segments. Government Operations makes naval nuclear reactors, cores and fuel for the Naval Nuclear Propulsion Program, downblends uranium and runs government sites through joint ventures; its subsidiary NFS is the sole provider of nuclear fuel for the U.S. Navy. Commercial Operations makes steam generators, reactor components and CANDU fuel and is the only commercial heavy nuclear component maker in North America.
current state · 2025-12-31written 2026-10-05
C06facthigh confidence
The NRC has licensed two Category I fuel fabrication plants, which may hold weapons-grade uranium: Nuclear Fuel Services in Erwin, Tennessee and the BWXT Nuclear Operations Group plant in Lynchburg, Virginia. Both belong to BWXT.
current state · 2026-10-05written 2026-10-05
C07facthigh confidence
NFS makes the fuel for all U.S. naval nuclear reactors, and BWXT fuel and reactors power the Ohio, Virginia, Seawolf, Los Angeles and Columbia-class submarines and the Nimitz and Ford-class carriers. On 1 October 2026 BWXT announced a naval fuel contract of about $189M, to be completed in August 2027.
current state · 2026-10-01written 2026-10-05
C08facthigh confidence
The 10-K says competition for naval components and fuel is limited by technical and regulatory standards, classified designs and high capital and licensing costs, and that naval contracts bill allowable costs under federal acquisition rules. It names Framatome, Cameco, Doosan, AECON, Westinghouse and AtkinsRéalis as Commercial Operations competitors, competing on price, technical ability, quality and timeliness.
current state · 2025-12-31written 2026-10-05

How it makes money

About 68% of sales come from the US government. The Navy orders reactors and fuel years ahead and pays BWXT's allowed costs plus a fee, so the money is steady but the margin is capped.

The commercial half is paid by utilities, roughly half for manufacturing parts and half for services and engineering. That money depends on plants being refurbished or built, and BWXT has to win each job on price.

The evidence under this - 4 claims
C02facthigh confidence
2025 revenue was $3,198.4M, up 18.3% from $2,703.7M: Government Operations $2,350.1M and Commercial Operations $853.1M. Operating income was $404.5M, net income $329.9M, diluted EPS $3.58 ($4.01 adjusted), adjusted EBITDA $574.3M and free cash flow $295.3M.
historical · FY 2025written 2026-10-05
C05facthigh confidence
Sales to the U.S. Government were $2,200.0M of 2025's $3,198.4M revenue, about 68%, against about 76% in 2024 and 75% in 2023. The U.S. Government was 91% of Government Operations revenue, and large utilities were 63% of Commercial Operations revenue.
historical · FY 2025written 2026-10-05
C27facthigh confidence
Commercial Operations' 2025 revenue was $429.2M from nuclear manufacturing and $423.8M from services and engineering, against $288.8M and $235.2M in 2024; $684.9M of it came from Canadian customers.
historical · FY 2025written 2026-10-05
C08facthigh confidence
The 10-K says competition for naval components and fuel is limited by technical and regulatory standards, classified designs and high capital and licensing costs, and that naval contracts bill allowable costs under federal acquisition rules. It names Framatome, Cameco, Doosan, AECON, Westinghouse and AtkinsRéalis as Commercial Operations competitors, competing on price, technical ability, quality and timeliness.
current state · 2025-12-31written 2026-10-05
Where the money comes from, stream by stream
StreamShare of sales (FY 2025)How it earns it
Nuclear components and fuel56.1%Naval reactors, cores and fuel for the Navy's submarines and carriers, plus valves and fittings.
Uranium processing and nuclear services12.7%Downblending, depleted uranium and enrichment programmes for NNSA, and government site services.
Advanced reactor design and engineering4.6%Government-funded microreactor and space reactor work, including Pele and now Janus.
Commercial nuclear manufacturing13.4%Steam generators, reactor parts and CANDU fuel for utilities, mostly in Canada.
Commercial nuclear services and engineering13.2%Plant inspection, refurbishment, engineering and the medical isotope business being sold.

Who runs it

Rex Geveden has run BWXT since 2017. Over the last five years it beat its own growth targets, partly through acquisitions. Insiders own under 1% of the company, and the chief executive sold 40,000 shares in the past year under a plan set in advance.

Most of the yearly bonus rides on operating profit and cash, and the long-term award on profit and the return on money invested, so pay follows profit, not sales.

The evidence under this - 5 claims
C42facthigh confidence
Rex Geveden has been chief executive since January 2017 after a year as chief operating officer; Michael Fitzgerald, at BWXT since 2022, became chief financial officer in 2025; Joseph Miller runs Government Operations.
current state · 2026-03-18written 2026-10-05
C41facthigh confidence
At 6 March 2026 the chief executive owned 300,823 shares and all 20 directors and officers 499,840, under 1%; BlackRock held 10.3% and Vanguard 10.1%.
current state · 2026-03-06written 2026-10-05
C40facthigh confidence
The 2025 annual bonus paid on operating income (70%), free cash flow (25%) and safety (5%), with a 133.4% financial multiplier; long-term performance units pay on cumulative adjusted EBITDA (40%), average return on invested capital (40%) and relative shareholder return (20%), and the 2023 to 2025 award paid 127.2%.
historical · FY 2025written 2026-10-05
C25facthigh confidence
In the year to October 2026 insiders made 22 open-market sales of 45,744 shares and no purchases; 40,000 shares, all the chief executive's, were sold under a 10b5-1 plan, and 5,744 by the CFO, the accounting chief and a director were discretionary, at $208.61 to $214.71. The 2026Q3 bought-to-sold ratio was 0.50 against a 12-quarter median of 2.38.
historical · 2025-10-24 to 2026-10-05written 2026-10-05
C37management claimmedium confidence
Management says that against its last Investor Day targets of mid-single-digit growth it delivered 15% yearly revenue growth (8.5% organic), 12% adjusted EBITDA growth and 18% free cash flow growth.
against this

Part of the 15% was bought: organic growth was 8.5%, and the Kinectrics acquisition added revenue the old targets never assumed.

historical · 2021 to 2026written 2026-10-05
02

Why it wins, and who could beat it

Why customers come back

The regulator has licensed exactly two plants in America to handle the highly enriched uranium naval fuel needs, and BWXT owns both. The reactor designs are classified, and the Navy has no second supplier to turn to.

So nobody can take this work away. But the protection does not mean high prices: the Navy pays cost plus a fee, and the shipyards set the pace, building barely more than one Virginia-class submarine a year against a goal of two.

The evidence under this - 4 claims
C06facthigh confidence
The NRC has licensed two Category I fuel fabrication plants, which may hold weapons-grade uranium: Nuclear Fuel Services in Erwin, Tennessee and the BWXT Nuclear Operations Group plant in Lynchburg, Virginia. Both belong to BWXT.
current state · 2026-10-05written 2026-10-05
C07facthigh confidence
NFS makes the fuel for all U.S. naval nuclear reactors, and BWXT fuel and reactors power the Ohio, Virginia, Seawolf, Los Angeles and Columbia-class submarines and the Nimitz and Ford-class carriers. On 1 October 2026 BWXT announced a naval fuel contract of about $189M, to be completed in August 2027.
current state · 2026-10-01written 2026-10-05
C09facthigh confidence
CRS reports the Navy bought two Virginia-class submarines a year from FY2011 to FY2024 and one in FY2025, at about $5.0B each, and requested two for FY2026. Actual production has never reached 2.0 boats a year and since 2022 has been about 1.1 to 1.2; the goal is 2.0 and then 2.33 with AUKUS.
current state · 2026-01-26written 2026-10-05
C31inferencemedium confidence
The naval half is a structural monopoly on volume but not on price: only BWXT's two plants may make the fuel, designs are classified, and the Navy has no other supplier, yet contracts bill allowable cost plus fee, so the shelter shows up as steady orders at about a 21% margin before depreciation.
derivedThe licences (C06), sole supply to every class (C07), the 10-K on limited competition and cost-based pricing (C08), and Q2 2026 segment margin (C03).
against this

Naval Reactors owns the designs, so the customer controls the technology and could in principle license a second maker; none is proposed (S01).

current state · 2026-06-30written 2026-10-05

The threat

The naval half has no rival. The commercial half does. Doosan in Korea supplied the big parts for every recent US reactor, and Curtiss-Wright sells pumps for the same design. Being North America's only heavy-parts maker wins no order on its own.

In newer markets, other companies are building the special fuel small reactors need, and four rivals were picked beside BWXT for the Army's microreactor programme.

The evidence under this - 5 claims
C15facthigh confidence
Doosan was selected to supply major equipment, including steam generators and reactor vessels, for all four US AP1000 units built at Vogtle and V.C. Summer.
historical · 2008written 2026-10-05
C16facthigh confidence
Curtiss-Wright's 10-K says it supplies reactor coolant pumps and control rod drive mechanisms for the Westinghouse AP1000 and products supporting naval nuclear propulsion; its Naval & Power segment had $1,503.0M of 2025 sales, 43% of the company.
current state · 2025-12-31written 2026-10-05
C49inferencemedium confidence
The commercial half sells into a contested market: Doosan built every US AP1000 component set, Framatome and Westinghouse sell the same parts and services, and Curtiss-Wright sells AP1000 pumps, so being North America's only heavy maker wins no order by itself.
derivedDoosan's AP1000 record (C15), the 10-K's named rivals and price competition (C08), and Curtiss-Wright's 10-K (C16).
against this

BWXT says reactor vendors such as Westinghouse and GE Vernova need very large components and it is adding about 40% to its heavy-component bay (S09).

current state · 2026-10-05written 2026-10-05
C17management claimmedium confidence
Management says BWXT makes a few hundred kilograms of TRISO fuel a year at Lynchburg, that TRISO-X, Standard Nuclear and others are entering, and that it is not yet ready to commit capital to a commercial TRISO plant in Wyoming with Kairos. The NRC lists TRISO-X and Kairos among new fuel plant applications.
current state · 2026-08-03written 2026-10-05
C14facthigh confidence
On 31 August 2026 the Army said its Janus programme selected five vendors to own, build and run microreactors on bases, with up to $2.2B across FY2027 to FY2031 paid only on technical milestones, contractor-owned reactors and significant vendor investment. BWXT's 20 MWe BANR will go to Fort Campbell, targeting groundbreaking in late 2028 and operation in the early 2030s; Tata Chemicals signed a letter of intent for up to eight units.
current state · 2026-08-31written 2026-10-05

The rivals: CW, BEP, CCJ, LEU, XE, STDN, and 3 more that are private, in-house or listed abroad.

Who else does this, rival by rival
TickerRivalWhere it competesHow far alongPriced against it
Doosan EnerbilityPriced against it: Listed abroadCommercial OperationsOn saleListed abroad
Not listedFramatomePriced against it: Not listedCommercial OperationsOn saleNot listed
CWCurtiss-Wright, Naval & PowerPriced against it: Same productCommercial OperationsOn saleSame product
AtkinsRéalis (Candu Energy) and AeconPriced against it: Listed abroadCommercial OperationsOn saleListed abroad
BEP · CCJWestinghouse, Radiant, Antares and General Atomics in the Army's Janus programmePriced against it: One segment onlyGovernment OperationsAnnouncedOne segment only
LEUCentrus Energy, for national-security enrichmentPriced against it: One segment onlyGovernment OperationsAnnouncedOne segment only
XE · STDNTRISO-X (X-energy) and Standard NuclearPriced against it: One segment onlyGovernment OperationsAnnouncedOne segment only
03

How big it could get

How big this could get

The naval prize is set by how many boats the Navy builds. The plan is two Virginia-class and one Columbia-class submarine a year, each needing one BWXT reactor, plus a carrier every four years.

Shipyards have built only 1.1 to 1.2 Virginia-class boats a year since 2022, so BWXT already makes over half of what the plan would need. Growth comes when the yards speed up, not from winning share.

The evidence under this - 3 claims
C09facthigh confidence
CRS reports the Navy bought two Virginia-class submarines a year from FY2011 to FY2024 and one in FY2025, at about $5.0B each, and requested two for FY2026. Actual production has never reached 2.0 boats a year and since 2022 has been about 1.1 to 1.2; the goal is 2.0 and then 2.33 with AUKUS.
current state · 2026-01-26written 2026-10-05
C10management claimmedium confidence
Management says the Navy's plan is two Virginia-class and one Columbia-class submarine a year, with Ford carriers moving to a four-year order cadence; BWXT produces 'at least two a year, more like three a year' naval reactors and has delivered 425. A nuclear battleship is not in its forecast.
against this

CRS reports the yards have built only 1.1 to 1.2 Virginia boats a year since 2022 and never 2.0 (C09).

forwardwritten 2026-10-05
C07facthigh confidence
NFS makes the fuel for all U.S. naval nuclear reactors, and BWXT fuel and reactors power the Ohio, Virginia, Seawolf, Los Angeles and Columbia-class submarines and the Nimitz and Ford-class carriers. On 1 October 2026 BWXT announced a naval fuel contract of about $189M, to be completed in August 2027.
current state · 2026-10-01written 2026-10-05

Who has signed

The Navy and the nuclear weapons agency have signed: backlog reached $8.6B in September, up from $7.3B at the end of 2025, including a new $1.5B enrichment programme.

The commercial backlog rose to $2.1B from $1.6B, but a business bought on 1 July is part of it, and no large new-reactor order is signed.

The evidence under this - 3 claims
C04facthigh confidence
Backlog was $8,556.2M at 30 September 2026 against $8,398.1M at 30 June 2026 and $7,261M at 31 December 2025: Government Operations $6,482M (from $6,797.6M at 30 June) and Commercial Operations $2,074M (from $1,600.5M). The Commercial figure includes Precision Components Group, bought on 1 July 2026 for about $216.8M. The 10-Q excludes about $1,400M of unexercised options.
  1. 2026-11-02edited30 September backlog from the 10-Q: Commercial rose, partly by acquisition, and Government fell
current state · 2026-09-30written 2026-10-05
C07facthigh confidence
NFS makes the fuel for all U.S. naval nuclear reactors, and BWXT fuel and reactors power the Ohio, Virginia, Seawolf, Los Angeles and Columbia-class submarines and the Nimitz and Ford-class carriers. On 1 October 2026 BWXT announced a naval fuel contract of about $189M, to be completed in August 2027.
current state · 2026-10-01written 2026-10-05
C18management claimmedium confidence
Management says NNSA awarded BWXT $1.5B in September 2025 to industrialise the DUECE centrifuge and plan unobligated enrichment through highly enriched uranium, and $1.63B to deliver 2,000 metric tons of high-purity depleted uranium; all the equipment must be US-sourced, and a prototype centrifuge is due in 2026.
against this

Centrus says its AC100M is the only production-ready technology for national-security enrichment (C19), and management itself questions whether unobligated enrichment is commercially viable (S08).

current state · 2026-09-29written 2026-10-05
Where the growth is coming from, business by business

Where the growth is coming from

BusinessShare of revenueGrowth: last quarterLast half-yearLast year
Government Operations67%+3.6%+3.8%+4.1%
Commercial Operations33%+25.2%+57.6%+77.8%
Whole company100%+9.9%+17.0%+20.1%

The filed split through 2026-09-30. These rates are not carried forward: the reading below says why.

How we read it: The score believes the blend, not Commercial's 107%: that rate is mostly Kinectrics and PCG, bought, and the organic commercial rate was 33% in Q2 2026.

04

The results

The numbers

Is it growing?Steady

Sales grew 18% over the twelve months to Sep 2026, about the same pace as the 18% in the year to Dec 2025.

Dec 2021: $2.12BDec 2022: $2.23BDec 2023: $2.50BDec 2024: $2.70BDec 2025: $3.20B12 mo to Sep 2026: $3.60B$2.12B$3.60B
Is it profitable?Healthy

Operating margin is 12%, down from 15% in the year to Dec 2023.

Dec 2021: 16%Dec 2022: 16%Dec 2023: 15%Dec 2024: 14%Dec 2025: 13%12 mo to Sep 2026: 12%16%12%
How steady is it?Uneven

Yearly sales growth has ranged from +0.0% to +18% over the last 5 years.

Dec 2021: +0.0%Dec 2022: +5.1%Dec 2023: +12%Dec 2024: +8.3%Dec 2025: +18%+0.0%+18%
Does it earn good returns?Decent

Each dollar put into the business earns 12% a year after tax, about where it was (16%) in the year to Dec 2021.

Dec 2021: 16%Dec 2022: 14%Dec 2023: 14%Dec 2024: 14%Dec 2025: 12%12 mo to Sep 2026: 12%16%12%
Is it making cash?Solid

It turned 10% of sales into free cash, $372M over the last twelve months.

Dec 2021: $75.0MDec 2022: $46.4MDec 2023: $212MDec 2024: $255MDec 2025: $295M12 mo to Sep 2026: $372M$75.0M$372M
Is the balance sheet safe?Heavy debt

It owes $1.45B more than the cash it holds, about 2.5 years of the cash its operations bring in.

Dec 2021: −$1.15BDec 2022: −$1.25BDec 2023: −$1.13BDec 2024: −$981MDec 2025: −$1.52B12 mo to Sep 2026: −$1.45B−$1.15B−$1.45B
Are shares being diluted?Stable

The share count fell 2.7% in 4.8 years, and pay in shares costs 1.0% of sales.

Dec 2021: 94.5MDec 2022: 91.7MDec 2023: 91.9MDec 2024: 91.9MDec 2025: 91.9M12 mo to Sep 2026: 92.0M94.5M92.0M
All the numbers

Filed figures from the company's 10-K and 10-Q, read 2026-11-10. Fiscal years end in December.

Dec 2021Dec 2022Dec 2023Dec 2024Dec 202512 mo to Sep 2026
Size and growth
Sales$2.12B$2.23B$2.50B$2.70B$3.20B$3.60B
Sales growth+0.0%+5.1%+12%+8.3%+18%+18%
Profit
Gross margin26%25%25%24%23%-
Operating margin16%16%15%14%13%12%
Net margin14%11%9.8%10%10%10%
What growth costs, per sales dollar
Research and development0.5%0.4%0.3%0.3%0.4%0.4%
Selling, general and admin11%10%11%12%12%12%
Pay in shares0.9%0.7%0.6%0.8%0.8%1.0%
Capital spending15%8.9%6.1%5.7%5.8%5.7%
Cash
Cash from operations$386M$245M$364M$408M$480M$579M
Free cash flow$75.0M$46.4M$212M$255M$295M$372M
Balance sheet
Cash and short-term investments$37.7M$39.0M$75.8M$74.1M$500M$569M
Debt$1.19B$1.29B$1.21B$1.06B$2.02B$2.02B
Net cash−$1.15B−$1.25B−$1.13B−$981M−$1.52B−$1.45B
Returns and shares
Return on capital16%14%14%14%12%12%
Shares (diluted)94.5M91.7M91.9M91.9M91.9M92.0M

What growth costs

Growing has made BWXT less profitable so far: the businesses it bought and the new government programmes earn thinner margins than naval reactors. Factories cost a steady slice of sales each year. The plan says margins recover by 2030; that is a promise, not yet a trend.

The evidence under this - 4 claims
C43facthigh confidence
Operating margin fell from 16.3% in 2021 to 12.6% in 2025 as revenue grew from $2,124.1M to $3,198.4M, and adjusted EBITDA margin is guided to about 17.5% in 2026 against 18.0% in 2025, before a 20% target for 2030.
historical · FY 2021 to FY 2026 guidewritten 2026-10-05
C44facthigh confidence
2025 operating cash flow was $479.8M and capital spending $184.6M, about 5.8% of revenue; management guides capital spending of 6% to 7% of sales in 2026 and 5% to 6% to 2030.
historical · FY 2025written 2026-10-05
C13facthigh confidence
BWXT bought A.O.T. (closed 3 January 2025), Kinectrics (closed 20 May 2025) and Precision Components Group (closed 1 July 2026). Commercial Operations revenue grew 72% in Q2 2026, 33% of it organic, and from $524.0M to $853.1M in 2025.
historical · FY 2025 and Q2 2026written 2026-10-05
C11management claimmedium confidence
At its 29 September 2026 Investor Day BWXT targeted 2030 revenue of $5.5B to $6B, adjusted EBITDA of $1.1B to $1.2B, free cash flow of $525M to $575M and over $2B of cumulative free cash flow from 2026 to 2030. It guided Government Operations to high single to low double-digit yearly revenue growth, with naval propulsion in mid single digits, and Commercial to high-teens revenue growth with its EBITDA margin rising from about 13% and EBITDA growing over 20% a year.
against this

Government Operations adjusted EBITDA fell in Q2 2026 (C03), and over half of Commercial's Q2 growth was acquired (C13).

forwardwritten 2026-10-05

The last report (2 Nov)

Quarter ended September 2026, filed figures.

10%
Sales growth
against the same quarter a year earlier
5.7%
Growth from the quarter before
against 4.8% the quarter before that
14¢
Operating profit
per dollar of sales

Sales rose 10% to $953.0M in the third quarter of 2026. The naval half grew 4%, but its profit before interest, tax and depreciation rose 22% to $144.2M from $118.3M, after falling in the June quarter.

The commercial half grew 25% and its profit rose 17%. Its backlog reached $2.1B, but that includes a business BWXT bought on 1 July, and no large new-reactor order was reported.

The company tightened its 2026 forecast, to about $667M of profit and $4.72 to $4.77 a share, and gave a first 2027 outlook of high-single-digit sales growth.

What it did to the thesisIt did not move the view. The naval profit jump is the first support for the plan since the June fall, but it is one quarter, naval sales grew only slightly, and no new-reactor order came. The price still waits on the plan.

The quarter in detail

Sales growth from the previous quarter, filed figures.

Earnings per share $1.26 against $1.18 expected.

The evidence under this - 4 claims
C03facthigh confidence
In Q3 2026 revenue was $953.0M, up 10%: Government Operations $639.1M, up 4%, and Commercial Operations $314.2M, up 25%. Government Operations adjusted EBITDA rose 22% to $144.2M from $118.3M and its operating income 26% to $122.6M from $97.4M; Commercial adjusted EBITDA rose 17% to $41.4M from $35.5M. Diluted EPS was $1.11 ($1.26 adjusted) and free cash flow $150.5M. In Q2 2026 Government Operations adjusted EBITDA had fallen to $126.5M from $133.0M.
  1. 2026-11-02editedQ3 2026 replaces Q2: the naval half's profit rose 22% after falling in Q2
historical · Q3 2026written 2026-10-05
C04facthigh confidence
Backlog was $8,556.2M at 30 September 2026 against $8,398.1M at 30 June 2026 and $7,261M at 31 December 2025: Government Operations $6,482M (from $6,797.6M at 30 June) and Commercial Operations $2,074M (from $1,600.5M). The Commercial figure includes Precision Components Group, bought on 1 July 2026 for about $216.8M. The 10-Q excludes about $1,400M of unexercised options.
  1. 2026-11-02edited30 September backlog from the 10-Q: Commercial rose, partly by acquisition, and Government fell
current state · 2026-09-30written 2026-10-05
C12management claimmedium confidence
On 2 November 2026 BWXT reaffirmed 2026 revenue of about $3.8B and tightened adjusted EBITDA to about $667M (from $662M to $672M), non-GAAP EPS to $4.72 to $4.77 (from $4.70 to $4.80) and free cash flow to $350M to $360M (from $345M to $360M). It introduced a preliminary 2027 outlook of high-single-digit revenue growth and high-single-digit to low-double-digit growth in adjusted EBITDA and EPS. The August split (Government Operations up high single digits, Commercial up about 45%) is not restated in the release.
against this

Government Operations revenue grew 2% in Q2 and 4% in Q3 2026 (C03), against the August guide of high-single-digit growth for the year.

  1. 2026-11-02editedQ3 release tightened the 2026 guide and gave a first 2027 outlook
forwardwritten 2026-10-05
C13facthigh confidence
BWXT bought A.O.T. (closed 3 January 2025), Kinectrics (closed 20 May 2025) and Precision Components Group (closed 1 July 2026). Commercial Operations revenue grew 72% in Q2 2026, 33% of it organic, and from $524.0M to $853.1M in 2025.
historical · FY 2025 and Q2 2026written 2026-10-05
What management did with the money

Management spent on growth: it bought Kinectrics and Precision Components Group to build the commercial half, and is selling the medical business for $750M. It plans no share buybacks in 2026, and borrowed $1.25B through bonds that convert into shares.

Insiders in 2026Q3: 5 purchases and 10 sales, from their Form 4 filings.

The evidence under this - 4 claims
C13facthigh confidence
BWXT bought A.O.T. (closed 3 January 2025), Kinectrics (closed 20 May 2025) and Precision Components Group (closed 1 July 2026). Commercial Operations revenue grew 72% in Q2 2026, 33% of it organic, and from $524.0M to $853.1M in 2025.
historical · FY 2025 and Q2 2026written 2026-10-05
C35facthigh confidence
BWXT agreed to sell BWXT Medical to Nordic Capital for $750M, up to $800M with contingent payments, keeping about 20%; it is about $130M of 2026 revenue, and closing is expected in 2026 or Q1 2027.
current state · 2026-06-30written 2026-10-05
C24facthigh confidence
Diluted shares were 92.0M in Q2 2026 against 91.7M a year earlier. In 2025 BWXT bought back $30M of stock and paid $92.5M of dividends; it plans no buybacks in 2026.
historical · FY 2025 and Q2 2026written 2026-10-05
C23facthigh confidence
At 30 September 2026 BWXT held $568.5M of cash against $2,021.9M of long-term debt ($499.8M and $2,016.0M at 31 December 2025), with no borrowings or repayments in the nine months. At 30 June the debt was $400M of 4.125% notes due 2028, $400M due 2029 and $1.25B of 0% convertible notes due 2030 converting at about $262.51 a share with a capped call to $396.24; the $1,248.6M revolving credit line was undrawn.
  1. 2026-11-02edited30 September cash and debt from the Q3 release; the note terms are those read in the Q2 10-Q
current state · 2026-09-30written 2026-10-05
05

The price, and where we disagree

In short. Priced for perfection. The price is about 148% of what we think the business is worth, at an 8% yearly return.

Share price
$139.92
close,
Company value for each $1 of cash profit
24.9
its 6-year normal 16.9

The shares are 44% below their high and close to their low for the year, while sales kept growing. That is the market paying less for the same business, not the business shrinking.

At its investor day on 29 September the company set 2030 targets of $5.5B to $6B of sales. The third-quarter report on 2 November gave naval profit growth but no new-reactor order; on the call the chief executive said a first one is possible by year-end and no later than the first half of 2027.

The evidence under this - 4 claims
C20facthigh confidence
Over 252 sessions to 2 October 2026 the share price fell 27.9% while sales per share rose 22.3%: the multiple fell 41.1%. The close of $134.86 was 44.2% below the 52-week high of $241.82 and 2.7% above the low.
historical · 2025-10-01 to 2026-10-02written 2026-10-05
C11management claimmedium confidence
At its 29 September 2026 Investor Day BWXT targeted 2030 revenue of $5.5B to $6B, adjusted EBITDA of $1.1B to $1.2B, free cash flow of $525M to $575M and over $2B of cumulative free cash flow from 2026 to 2030. It guided Government Operations to high single to low double-digit yearly revenue growth, with naval propulsion in mid single digits, and Commercial to high-teens revenue growth with its EBITDA margin rising from about 13% and EBITDA growing over 20% a year.
against this

Government Operations adjusted EBITDA fell in Q2 2026 (C03), and over half of Commercial's Q2 growth was acquired (C13).

forwardwritten 2026-10-05
C38facthigh confidence
BWXT beat the analysts' adjusted EPS estimate in each of its last nine quarters, most recently $1.26 against $1.18 in Q3 2026; revenue of $953.0M came in 1.8% under the estimate.
  1. 2026-11-02editedQ3 2026 extends the run of beats to nine
historical · Q3 2024 to Q3 2026written 2026-10-05
C29management claimlow confidence
On the Q2 2026 call management said there is 'a credible opportunity to secure at least one new build nuclear equipment order before the year-end'; on the Q3 2026 call (2 November) the chief executive said a first order for US reactor plant builds by the end of 2026 'is a possibility', and 'certainly no later than about the first half of the next year', with small modular reactors (Darlington, then Tennessee Valley Authority) ahead of large reactors and the gate being how risk is shared rather than financing.
against this

Commercial bookings fell to $464.0M in the first half from $721.6M a year earlier (C04).

  1. 2026-11-03editedQ3 2026 call restated the timing: still possible by year-end but now 'no later than about the first half' of 2027; the order is not signed.
forwardwritten 2026-10-05
The betSafe, little upside
If it works
0.9×
from today's value, at the stated multiple
If it fails
keep 77%
of today's market value: the rest of the company and Commercial Operations stalled at its lowest case, less debt
How we value it
Method
Cash the business will produce, in three stages
Required return
8%
Long-run growth
4%
Moat
An average moat
BearBaseBull
Sales growth, years 1 to 35.9%, 4.8%, 4.9%11.9%, 9.5%, 9.8%14.9%, 11.9%, 12.2%
Normal operating margin11%13.7%15.1%
Return on new capital after year ten8%12%15%
Value a share$37.86$80.93$111
Price
$120
Priced on
6 Nov
Price as a share of the base value
148%
Starting growth the price pays for
29.9%
Yearly return the price offers on the base case
6.9%
Risk check: valued at 10%, the rate for a cyclical or indebted business
$46.85

Where each figure comes from

FigureSourceWhere exactly
Sales, the last twelve monthsFiled reportQuarterly report (10-Q) for the period to 30 Sep 2026, filed 2 Nov 2026; the four quarters to that date.
Operating margin todayFiled reportQuarterly report (10-Q) for the period to 30 Sep 2026, filed 2 Nov 2026; the four quarters to that date.
Tax rateFiled reportQuarterly report (10-Q) for the period to 30 Sep 2026, filed 2 Nov 2026; the four quarters to that date.
Sales per dollar of new capitalFiled reportAnnual report (10-K) for the period to 31 Dec 2025, filed 23 Feb 2026: the year's sales over its operating capital.
SharesFiled reportQuarterly report (10-Q) for the period to 30 Sep 2026, filed 2 Nov 2026; the diluted share count.
Cash and investmentsFiled reportQuarterly report (10-Q) for the period to 30 Sep 2026, filed 2 Nov 2026; the balance sheet on that date.
DebtFiled reportQuarterly report (10-Q) for the period to 30 Sep 2026, filed 2 Nov 2026; the balance sheet on that date.
Sales growth, years 1 to 3Analysts' forecastsFMP's consensus for the years to 31 Dec 2026, 31 Dec 2027, 31 Dec 2028 and 31 Dec 2029: the average of 8 to 14 analysts' revenue estimates, 12.1%, 9.4%, 9.6%. FMP publishes how many analysts, not who they are.
Normal operating marginAnalysts' forecastsFMP's consensus operating margin for the year to 31 Dec 2028, the average of 14 analysts' estimates, 16.2%, less stock pay of 1% of sales and less the 1.5% the analysts add back on their adjusted basis. FMP publishes how many analysts, not who they are.
Return on new capital after year tenOur method's ruleSet by our reading of the moat: the 8% rate with none, 12% with an average one, 15% with a strong one; the bear case earns the rate.
The bear and bull casesOur method's ruleOur method's spread: the bear case takes half the growth and a fifth off the margin, the bull a quarter more growth and a tenth more margin.
PriceMarket priceFMP's closing price on 6 Nov 2026.

What each case rests on

Bear caseGrowth runs at half the analysts' path, 6%, 5% and 5%, the margin settles a fifth lower at 11.0%, and new capital earns only the 8% rate: the downturn test.

Base caseRevenue grows 12%, 10% and 10% over three years, the analysts' path (C56), then fades toward 4%, closing 30% of the gap each year; the margin moves to 13.7%, the analysts' year-three figure after stock pay and on the filed basis (1.5% less).

Bull caseGrowth runs a quarter above the analysts' path, 15%, 12% and 12%, the margin reaches 15.1%, and new capital earns 15%.

What moves the base value

LowerHigher
Growth in years 1 to 3, a quarter lower or higher$73.36$89.21
The normal margin, 15% lower or higher$65.69$96.16
Capital per dollar of growth, a quarter more or less$76.50$83.58
Return on new capital after year ten, at the rate or one step up$60.74$89.00
The rate, a point higher or lower$60.46$115
Long-run growth a point lower$71.31-

Value a share as growth and margin change

Normal margin ↓ · growth →50%75%100%125%150%
11%$50.18$55.15$60.62$66.60$73.15
12.3%$58.32$64.26$70.77$77.91$85.71
13.7%$66.47$73.36$80.93$89.21$98.28
15.1%$74.61$82.47$91.08$101$111
16.4%$82.76$91.57$101$112$123

Growth is shown as a share of the base case's. Green: the price is at or under 80% of that value. Red: at or over 120%.

How we read the multiple

A buyer today pays for the whole company, debt included, against the profit it expects this year before interest, tax and depreciation.

To be back at its usual valuation, BWXT has to earn about $815M of that profit, against about $667M this year. On the company's own 2030 plan, that arrives between 2027 and 2028.

So the price is not stretched, but it already counts the next two years of growth. A buyer gains from here only if growth comes faster than the plan.

Against its own history. Buyers still pay more for each dollar of profit than they usually have, so the fall removed the nuclear-boom excitement without making the shares cheap.

The evidence under this - 4 claims
C22inferencemedium confidence
At $13.77B of company value the price is about 20.6 times the $667M midpoint of 2026 adjusted EBITDA guidance, against BWXT's 16.9 median in prior years. At 16.9 times the price needs about $815M, a level the 2030 plan's straight line reaches between 2027 and 2028.
derivedCompany value (C21) over the guidance midpoint (C12); $1.15B in 2030 from $667M in 2026 is about 14.6% a year, giving about $764M in 2027 and $876M in 2028 (C11).
against this

The 16.9 norm was struck when the company grew 5% to 8% a year; on the 2030 target midpoint the same company value is about 12 times (C11).

forwardwritten 2026-10-05
C12management claimmedium confidence
On 2 November 2026 BWXT reaffirmed 2026 revenue of about $3.8B and tightened adjusted EBITDA to about $667M (from $662M to $672M), non-GAAP EPS to $4.72 to $4.77 (from $4.70 to $4.80) and free cash flow to $350M to $360M (from $345M to $360M). It introduced a preliminary 2027 outlook of high-single-digit revenue growth and high-single-digit to low-double-digit growth in adjusted EBITDA and EPS. The August split (Government Operations up high single digits, Commercial up about 45%) is not restated in the release.
against this

Government Operations revenue grew 2% in Q2 and 4% in Q3 2026 (C03), against the August guide of high-single-digit growth for the year.

  1. 2026-11-02editedQ3 release tightened the 2026 guide and gave a first 2027 outlook
forwardwritten 2026-10-05
C21facthigh confidence
At the 2 October 2026 close market value was $12.36B and company value $13.77B; trailing P/E was 34.8 against a 25.5 median in prior fiscal years, and company value was 24.9 times trailing EBITDA against 16.9. Return on invested capital was 8% against a 13% median.
current state · 2026-10-02written 2026-10-05
C11management claimmedium confidence
At its 29 September 2026 Investor Day BWXT targeted 2030 revenue of $5.5B to $6B, adjusted EBITDA of $1.1B to $1.2B, free cash flow of $525M to $575M and over $2B of cumulative free cash flow from 2026 to 2030. It guided Government Operations to high single to low double-digit yearly revenue growth, with naval propulsion in mid single digits, and Commercial to high-teens revenue growth with its EBITDA margin rising from about 13% and EBITDA growing over 20% a year.
against this

Government Operations adjusted EBITDA fell in Q2 2026 (C03), and over half of Commercial's Q2 growth was acquired (C13).

forwardwritten 2026-10-05
Priced against its rivals

Only Curtiss-Wright sells the same thing to the same buyers as a large part of what it does. A price comparison needs at least two, so the price is judged against its own history instead.

Private or foreign rivals that cannot be priced: Framatome, Westinghouse Electric Corporation, Bechtel National, Inc., Doosan Enerbility (formerly Doosan Heavy Industries & Construction), AECON Group Inc., AtkinsRéalis.

The bet: what it pays if it works

The bet is the commercial half: power-plant parts and services, and new reactors if orders come. The naval half is the floor.

The long case in the verdict is the chief executive's, and its direction checks out, though his gas fuel figure is generous. The work it favours is what Canadian utilities already buy from BWXT.

At the investor day pace the shares are worth their price; they pay well only if new-reactor orders come early.

Commercial Operations EBITDA in two to three yearsDollars of commercial adjusted EBITDA neededAt the stated multiple
$145.00Mabout 145.0M at 100% kept0.8×
$210.00M (the big win)about 210.0M at 100% kept0.9×
$300.00Mabout 300.0M at 100% kept1.0×

To pay 2× (a Fair bet) it would need about $983.64M of Commercial Operations EBITDA (about 983.6M dollars of commercial adjusted EBITDA); to pay 5× (a Cheap bet), about $3.12B of Commercial Operations EBITDA (about 3.1B dollars of commercial adjusted EBITDA), at the same multiple.

Each row is Commercial Operations alone, plus the rest of the company (Government Operations) counted at about $8.79B.

The steps it has to take

  • Done Kinectrics acquired
  • Done Precision Components Group acquired
  • In progress Medical business sold to Nordic Capital due 2027-03
  • Not started First new-build large reactor equipment order signed due 2026-12
  • Not started Commercial EBITDA margin reaches the 2030 high teens due 2030-12
The detail behind the label
Rating
Expensive
the big win's payoff against the 2× and 5× lines
Cheap bet at about
≈ $12.94
91% below the price (close, )
The option
0.8×
what Commercial Operations is worth if it works, against what the price pays for it
The evidence under this - 6 claims
C34estimatelow confidence
Commercial Operations without the medical business should earn about $145M of adjusted EBITDA in 2026, about 13% of the $1.1B of revenue management expects; at the Investor Day's 20% yearly growth that is about $210M in 2028.
derivedThe 13% segment margin guide (C12), management's $1.1B of 2026 commercial revenue without medical (S09) and its over-20% EBITDA growth target (C11).
against this

First-half commercial bookings fell 36% (C04), and the growth target assumes new-build orders not yet signed (C29).

forwardwritten 2026-10-05
C29management claimlow confidence
On the Q2 2026 call management said there is 'a credible opportunity to secure at least one new build nuclear equipment order before the year-end'; on the Q3 2026 call (2 November) the chief executive said a first order for US reactor plant builds by the end of 2026 'is a possibility', and 'certainly no later than about the first half of the next year', with small modular reactors (Darlington, then Tennessee Valley Authority) ahead of large reactors and the gate being how risk is shared rather than financing.
against this

Commercial bookings fell to $464.0M in the first half from $721.6M a year earlier (C04).

  1. 2026-11-03editedQ3 2026 call restated the timing: still possible by year-end but now 'no later than about the first half' of 2027; the order is not signed.
forwardwritten 2026-10-05
C11management claimmedium confidence
At its 29 September 2026 Investor Day BWXT targeted 2030 revenue of $5.5B to $6B, adjusted EBITDA of $1.1B to $1.2B, free cash flow of $525M to $575M and over $2B of cumulative free cash flow from 2026 to 2030. It guided Government Operations to high single to low double-digit yearly revenue growth, with naval propulsion in mid single digits, and Commercial to high-teens revenue growth with its EBITDA margin rising from about 13% and EBITDA growing over 20% a year.
against this

Government Operations adjusted EBITDA fell in Q2 2026 (C03), and over half of Commercial's Q2 growth was acquired (C13).

forwardwritten 2026-10-05
C33estimatemedium confidence
Government Operations should earn about $520M of adjusted EBITDA in 2026: 2025's $2,350.1M of revenue grown about 8% at the guided 20.5% margin.
derived2025 segment revenue (C02) and the 2026 segment guide (C12).
against this

Government Operations grew 2% in Q2 2026 and its adjusted EBITDA fell (C03).

forwardwritten 2026-10-05
C50management claimmedium confidence
At the 29 September 2026 Investor Day the chief executive argued that nuclear is a high fixed cost, low running cost asset and gas the reverse: fuel for a gigawatt of gas costs about $400M a year against about $60M for nuclear, gas turbines now cost about $3.5B a gigawatt with five or six years' delivery, about 600 large reactors were built in the 1970s to 1990s and many still run, and doubling a plant's life costs '30 cents on the dollar or whatever that is'.
against this
  • At US gas prices and heat rates the fuel gap is about four times, not nearly seven: about $219M against $50M a gigawatt-year (C51).
  • IAEA counts 446 reactors connected to the grid from 1970 to 1999, not about 600, and never more than 33 in a year where he said 15 or 20 a month (C53).
current state · 2026-09-29written 2026-10-05
C55inferencemedium confidence
The investor-day argument is a case for the commercial third, not the naval two thirds: life extension is the refurbishment work Canadian utilities already pay BWXT for, and long turbine queues make running old reactors longer the cheaper option. It supports demand for that work for years, but it is already inside the high-teens commercial plan the price is measured against.
derivedThe commercial revenue mix and its Canadian customers (C27), the economics as stated (C50) and checked (C51, C52, C54), and the plan the bet is struck on (C11, C34).
against this

First-half commercial bookings fell and the commercial backlog was flat, so the tailwind has not yet shown up in orders (C04).

forwardwritten 2026-10-05

Where we disagree with the market

The market believes

A nuclear-boom stock: small reactors, new power plants and AI power demand, now cheaper after a 44% fall.

We believe

Two thirds of it is a naval monopoly growing sales about 5% a year; its profit rose 22% last quarter after falling in the one before.

The boom story is mostly priced on businesses that earn little today: Army microreactors pay only on milestones into the 2030s, and new power-plant orders are not signed. What pays the bills is the Navy, and it grows at the pace of the shipyards.

Against us: analysts have turned more positive this year, and the company beat estimates in each of the last nine quarters.

What analysts say, and the evidence
Analysts positive
78%
of 18, 1 Oct
Four months earlier
69%
of 16, 1 Jun
The evidence under this - 5 claims
C26facthigh confidence
On 1 October 2026 77.8% of 18 analysts were positive, against 58.3% of 12 on 1 February; the snapshot reads 13 buy, 5 hold and 1 sell. Short interest was 3.5% of float at the 15 September settlement, up 7.9%.
current state · 2026-10-01written 2026-10-05
C20facthigh confidence
Over 252 sessions to 2 October 2026 the share price fell 27.9% while sales per share rose 22.3%: the multiple fell 41.1%. The close of $134.86 was 44.2% below the 52-week high of $241.82 and 2.7% above the low.
historical · 2025-10-01 to 2026-10-02written 2026-10-05
C03facthigh confidence
In Q3 2026 revenue was $953.0M, up 10%: Government Operations $639.1M, up 4%, and Commercial Operations $314.2M, up 25%. Government Operations adjusted EBITDA rose 22% to $144.2M from $118.3M and its operating income 26% to $122.6M from $97.4M; Commercial adjusted EBITDA rose 17% to $41.4M from $35.5M. Diluted EPS was $1.11 ($1.26 adjusted) and free cash flow $150.5M. In Q2 2026 Government Operations adjusted EBITDA had fallen to $126.5M from $133.0M.
  1. 2026-11-02editedQ3 2026 replaces Q2: the naval half's profit rose 22% after falling in Q2
historical · Q3 2026written 2026-10-05
C31inferencemedium confidence
The naval half is a structural monopoly on volume but not on price: only BWXT's two plants may make the fuel, designs are classified, and the Navy has no other supplier, yet contracts bill allowable cost plus fee, so the shelter shows up as steady orders at about a 21% margin before depreciation.
derivedThe licences (C06), sole supply to every class (C07), the 10-K on limited competition and cost-based pricing (C08), and Q2 2026 segment margin (C03).
against this

Naval Reactors owns the designs, so the customer controls the technology and could in principle license a second maker; none is proposed (S01).

current state · 2026-06-30written 2026-10-05
C14facthigh confidence
On 31 August 2026 the Army said its Janus programme selected five vendors to own, build and run microreactors on bases, with up to $2.2B across FY2027 to FY2031 paid only on technical milestones, contractor-owned reactors and significant vendor investment. BWXT's 20 MWe BANR will go to Fort Campbell, targeting groundbreaking in late 2028 and operation in the early 2030s; Tata Chemicals signed a letter of intent for up to eight units.
current state · 2026-08-31written 2026-10-05
06

What could go wrong, and how we would know

The risks

  • One buyer The US government is 68% of sales. A budget fight or a slower shipbuilding plan hits most of the company at once.
  • Shipyards set the pace BWXT cannot build reactors faster than the yards take them, and the yards have missed the two-a-year goal for over a decade.
  • Commercial orders are contested Doosan, Framatome and Curtiss-Wright sell the same parts, so a new-build boom need not mean BWXT orders.
  • Naval margins uneven Naval profit fell in the June quarter and rose 22% in the September one while new programmes ramped; if it swings back, the steady half stops being steady.
  • New programmes are long dated Microreactors and enrichment pay on milestones over years and may never earn a commercial return.
The evidence under this - 6 claims
C05facthigh confidence
Sales to the U.S. Government were $2,200.0M of 2025's $3,198.4M revenue, about 68%, against about 76% in 2024 and 75% in 2023. The U.S. Government was 91% of Government Operations revenue, and large utilities were 63% of Commercial Operations revenue.
historical · FY 2025written 2026-10-05
C09facthigh confidence
CRS reports the Navy bought two Virginia-class submarines a year from FY2011 to FY2024 and one in FY2025, at about $5.0B each, and requested two for FY2026. Actual production has never reached 2.0 boats a year and since 2022 has been about 1.1 to 1.2; the goal is 2.0 and then 2.33 with AUKUS.
current state · 2026-01-26written 2026-10-05
C49inferencemedium confidence
The commercial half sells into a contested market: Doosan built every US AP1000 component set, Framatome and Westinghouse sell the same parts and services, and Curtiss-Wright sells AP1000 pumps, so being North America's only heavy maker wins no order by itself.
derivedDoosan's AP1000 record (C15), the 10-K's named rivals and price competition (C08), and Curtiss-Wright's 10-K (C16).
against this

BWXT says reactor vendors such as Westinghouse and GE Vernova need very large components and it is adding about 40% to its heavy-component bay (S09).

current state · 2026-10-05written 2026-10-05
C03facthigh confidence
In Q3 2026 revenue was $953.0M, up 10%: Government Operations $639.1M, up 4%, and Commercial Operations $314.2M, up 25%. Government Operations adjusted EBITDA rose 22% to $144.2M from $118.3M and its operating income 26% to $122.6M from $97.4M; Commercial adjusted EBITDA rose 17% to $41.4M from $35.5M. Diluted EPS was $1.11 ($1.26 adjusted) and free cash flow $150.5M. In Q2 2026 Government Operations adjusted EBITDA had fallen to $126.5M from $133.0M.
  1. 2026-11-02editedQ3 2026 replaces Q2: the naval half's profit rose 22% after falling in Q2
historical · Q3 2026written 2026-10-05
C23facthigh confidence
At 30 September 2026 BWXT held $568.5M of cash against $2,021.9M of long-term debt ($499.8M and $2,016.0M at 31 December 2025), with no borrowings or repayments in the nine months. At 30 June the debt was $400M of 4.125% notes due 2028, $400M due 2029 and $1.25B of 0% convertible notes due 2030 converting at about $262.51 a share with a capped call to $396.24; the $1,248.6M revolving credit line was undrawn.
  1. 2026-11-02edited30 September cash and debt from the Q3 release; the note terms are those read in the Q2 10-Q
current state · 2026-09-30written 2026-10-05
C14facthigh confidence
On 31 August 2026 the Army said its Janus programme selected five vendors to own, build and run microreactors on bases, with up to $2.2B across FY2027 to FY2031 paid only on technical milestones, contractor-owned reactors and significant vendor investment. BWXT's 20 MWe BANR will go to Fort Campbell, targeting groundbreaking in late 2028 and operation in the early 2030s; Tata Chemicals signed a letter of intent for up to eight units.
current state · 2026-08-31written 2026-10-05
What we still do not know
  • What the Navy actually pays BWXT for one reactor and its core: only whole-boat costs and segment totals are public.
  • Whether naval profit growth of 22% in the September quarter is new programmes maturing or timing: the company names programmes, not the arithmetic.
  • Whether any new US or Canadian reactor order goes to BWXT rather than Doosan or Framatome.
The evidence under this - 3 claims
C31inferencemedium confidence
The naval half is a structural monopoly on volume but not on price: only BWXT's two plants may make the fuel, designs are classified, and the Navy has no other supplier, yet contracts bill allowable cost plus fee, so the shelter shows up as steady orders at about a 21% margin before depreciation.
derivedThe licences (C06), sole supply to every class (C07), the 10-K on limited competition and cost-based pricing (C08), and Q2 2026 segment margin (C03).
against this

Naval Reactors owns the designs, so the customer controls the technology and could in principle license a second maker; none is proposed (S01).

current state · 2026-06-30written 2026-10-05
C03facthigh confidence
In Q3 2026 revenue was $953.0M, up 10%: Government Operations $639.1M, up 4%, and Commercial Operations $314.2M, up 25%. Government Operations adjusted EBITDA rose 22% to $144.2M from $118.3M and its operating income 26% to $122.6M from $97.4M; Commercial adjusted EBITDA rose 17% to $41.4M from $35.5M. Diluted EPS was $1.11 ($1.26 adjusted) and free cash flow $150.5M. In Q2 2026 Government Operations adjusted EBITDA had fallen to $126.5M from $133.0M.
  1. 2026-11-02editedQ3 2026 replaces Q2: the naval half's profit rose 22% after falling in Q2
historical · Q3 2026written 2026-10-05
C29management claimlow confidence
On the Q2 2026 call management said there is 'a credible opportunity to secure at least one new build nuclear equipment order before the year-end'; on the Q3 2026 call (2 November) the chief executive said a first order for US reactor plant builds by the end of 2026 'is a possibility', and 'certainly no later than about the first half of the next year', with small modular reactors (Darlington, then Tennessee Valley Authority) ahead of large reactors and the gate being how risk is shared rather than financing.
against this

Commercial bookings fell to $464.0M in the first half from $721.6M a year earlier (C04).

  1. 2026-11-03editedQ3 2026 call restated the timing: still possible by year-end but now 'no later than about the first half' of 2027; the order is not signed.
forwardwritten 2026-10-05

What would change our view

  1. Unattractive→NeutralThe price falls back within 20% of fair value

    It needs:

    • ○The share price falls to about $97.12, back within 20% of what we think the business is worth.about ≈$99.87 today, 29% below the last close
  2. Unattractive→AttractiveThe price falls 20% under fair value

    It needs:

    • ○The share price falls to about $64.74, 80% of what we think the business is worth.about ≈$70.95 today, 49% below the last close
  3. Unattractive→AttractiveThe plan arrives faster than the price needs

    It needs all of:

    • ○The naval half grows its profit at least 8% from a year earlier in the fourth quarter of 2026.checked at the next results, due by 1 Mar
    • ○BWXT signs an equipment order for a new large reactor, as management expects by year-end.watched as it happens
We would also be wrong if
  • A second company is licensed to make naval reactor fuel or cores.
  • Congress funds fewer than two Virginia-class submarines a year again, or slows the Columbia class.

What is coming

  • December 2026 First new-build reactor equipment order: Whether the commercial plan's high-teens growth has an order behind it, and whether BWXT or Doosan wins it.
Every dated event ahead
  • December 2026 First new-build reactor equipment order: Whether the commercial plan's high-teens growth has an order behind it, and whether BWXT or Doosan wins it.
  • February 2027 Q4 2026 results and the 2026 10-K: 2026 against the $667M guide, 2027 guidance, and Government Operations' full-year growth.
  • March 2027 Medical sale closes: About $750M of cash that cuts net debt roughly in half, and the perimeter the 2027 guide is struck on.
  • December 2028 Janus groundbreaking at Fort Campbell: Whether BANR moves from selection to construction on the Army's milestone payments.
Since we wrote this
Written
5 Oct
Price the thesis read
$134.86
2 Oct
Latest close
$139.92
close, · +3.8% since
  • 9 NovThesis reviewUnattractive: priced at 144% of a value near $82.82Re-valued in three stages at an 8% return, the method now drawn on every thesis: the price sits beyond the 20% margin of safety.
  • 4 NovNewsBWXT is replacing $800M of 4.125% notes with a $500M new issue and cash. View heldRefinancing of the 2028 and 2029 notes.
  • 3 NovEarningsQ3 call: first reactor order possible by year-end, mid-2027 at latestManagement explained the naval profit jump and gave a softer date for the first new-reactor order; nothing signed, so Neutral at Medium holds.
  • 2 NovEarningsNaval profit rose 22% in Q3; no new-reactor order yetGovernment Operations profit jumped after June's fall, but sales grew 4% and the commercial order is still unsigned, so Neutral at Medium holds.
  • 13 OctBet moveBet re-struck: Priced for success to Safe, little upsideRe-priced at the 12 October close.
  • 10 OctBet moveBet re-struck: Safe, little upside to Priced for successRe-priced at the 9 October close.
  • 8 OctBet moveBet re-struck: Priced for success to Safe, little upsideRe-priced at the 7 October close.
  • 7 OctBet moveBet re-struck: Safe, little upside to Priced for successRe-priced at the 6 October close.
  • 6 OctNewsBWXT's small reactor is picked for a Canadian transportable nuclear plant project. View heldBANR microreactor chosen for a Canadian transportable nuclear plant project.
  • 5 OctThesis writtenNeutral, medium convictionWritten a week after the Investor Day and four weeks before Q3 2026 results, with the shares 44% below their high.
  • 5 OctThesis reviewOwner asked: the investor-day case for nuclear over gasThe owner asked why the chief executive's argument on fuel cost, turbine waits and life extension was missing; the first pass read the Investor Day for its targets only.

Also checked 3 times with nothing new to act on.

Sources 29

Where this came from

Sources - 29

Every claim above cites one of these, or states the reasoning that derived it. The quote is frozen at the date it was read: a link can rot, and an agent fetch returns a reading of a page rather than the page. Backs counts the whole claim ledger, so it can name a claim this page does not surface.

  1. S01primarycompany filing2026-02-23
    segments, facilities, competition, contract pricing, customer concentration, product-line and geographic revenue, acquisitions, cash flow and buybacks
    backsC01C02C05C06C07C08C13C24C27C43C44
  2. S02primarycompany filing2026-08-03
    segment results, backlog and its unfunded part, debt and convertible terms, cash, the medical sale and the PCG acquisition
    backsC04C13C21C23C35
  3. S03primarycompany release2026-02-23
    2025 adjusted EBITDA, non-GAAP EPS and free cash flow, and the first 2026 guidance
    backsC02
  4. S04primarycompany release2026-08-03
    the quarter by segment, the adjusted EBITDA reconciliation, backlog and bookings, share counts and raised 2026 guidance
    backsC13C21C24
  5. S05primaryregulator2026-10-05
    U.S. Nuclear Regulatory Commission: Fuel Fabrication U.S. Nuclear Regulatory Commission
    the two Category I licensees and the new Category II TRISO applications
    Two Category I fuel fabrication plants are currently licensed by the NRC: Nuclear Fuel Services (NFS) in Erwin, Tennessee and the BWXT Nuclear Operations Group plant in Lynchburg, Virginia.
    backsC06C17
  6. S06primarycompany release2026-10-01
    the contract's size and end date and the ship classes BWXT reactors power
    BWXT’s Nuclear Fuel Services facility processes highly enriched uranium to manufacture fuel for all U.S. naval nuclear reactors
    backsC07
  7. S07primarygovernment data2026-01-26
    boats bought and built a year, their cost, and the 2.0 and 2.33 goals
    the actual Virginia-class production rate has never reached 2.0 boats per year, and since 2022 has been limited to about 1.1 to 1.2 boats per year
    backsC09
  8. S08primarytranscript2026-08-03
    BWXT Q2 2026 earnings call transcript (FMP)
    the Navy plan, the new-build order expectation, TRISO capacity, DUECE progress, capital spending and the medical sale
    we believe there's a credible opportunity to secure at least one new build nuclear equipment order before the year-end
    backsC10C12C17C18C24C29C35C44
  9. S09primarytranscript2026-09-29
    the 2030 targets by segment, the DUECE and HPDU awards, content per reactor, the record against the last targets and capital allocation
    On revenue, we're targeting $5.5 billion-$6 billion in 2030, which is a low double-digit annual growth rate from 2026.
    backsC10C11C18C28C37C43C44C50
  10. S10secondarygovernment data2026-08-31
    five vendors, up to $2.2B over FY2027 to FY2031, milestone payments, contractor ownership; army.mil returned 403
    Using a milestone-based payment model, vendors will receive government funding only after successfully hitting specific technical goals.
    backsC14
  11. S11primarycompany release2026-08-26
    the Fort Campbell site, the 20 MWe design, the schedule and the Tata letter of intent
    BWXT is targeting groundbreaking for site construction in late 2028 with reactor operations commencing in the early 2030’s.
    backsC14
  12. S12secondarynews2008-06-05
    Doosan's steam generators and reactor vessels for Vogtle 3 and 4 and V.C. Summer 2 and 3
    Doosan has been selected to supply major equipment to all four units of US AP1000s
    backsC15
  13. S13primarytranscript2026-08-06
    Centrus Energy Q2 2026 earnings call transcript (FMP) Centrus Energy
    a rival's claim on national-security enrichment
    Centrus is the only viable production-ready technology that can meet national security needs
    backsC19
  14. S14secondaryvendor data2026-10-05
    Research pack (FMP market data, FINRA, SEC filed figures), frozen as research-pack.json
    price, the price decomposition, multiples against their history, earnings history, the analyst series, short interest, insider base rate and the five-year margin series
    backsC20C21C25C26C38C43
  15. S15primarycompany filing2026-03-18
    officers' biographies, beneficial ownership and the bonus and performance unit plans with their 2025 payouts
    backsC40C41C42
  16. S16primarycompany filing2026-02-12
    its AP1000 reactor coolant pumps and control rod drives, naval propulsion products and Naval & Power segment sales
    backsC16C36
  17. S17primarycompany filing2026-08-12
    each open-market sale with its 10b5-1 flag
    backsC25
  18. S18secondaryvendor data2026-10-05
    FMP trailing key metrics for Curtiss-Wright
    Curtiss-Wright's company value against trailing EBITDA
    backsC36
  19. S19primarygovernment data2025-10-01
    natural gas plants averaged 7,754 Btu per kWh in 2024
    Table 8.1. Average Operating Heat Rate for Selected Energy Sources, 2014 through 2024 (Btu per Kilowatthour)
    backsC51
  20. S20primarygovernment data2026-09-01
    monthly averages September 2025 to August 2026: $2.77 to $7.72, mean $3.59
    Henry Hub Natural Gas Spot Price, Dollars per Million Btu, Monthly
    backsC51
  21. S21primaryregulator2025-06-01
    grid connections by year (446 from 1970 to 1999, at most 33 in a year) and the age of the operating fleet
    About 67% of global operational reactor capacity (264.3 GW(e), 298 reactors) has been in operation for over 30 years, 35% (136.4 GW(e), 168 reactors) of the total installed capacity has been in operation for over 40 years.
    backsC53
  22. S22primarycompany filing2026-07-22
    116 GW of gas turbines under contract against 20 GW of yearly output, 24 GW in 2028 and 30 GW planned for 2030
    Gas Power equipment backlog and slot reservation agreements grew from 100 to 116 GW; now anticipate reaching at least 125 GW by year-end 2026
    backsC52
  23. S23secondaryindustry data2026-06-05
    the C$12.8B refurbishment of Darlington's four 878-MWe units, extending their lives by 30 years, and the C$20.9B envelope for four 300-MWe BWRX-300s at the same site
    OPG is working with a C$20.9 billion project envelope and a similar strategy for the DNNP.
    backsC54
  24. S24primarygovernment data2025-10-01
    nuclear fuel cost 6.37 mills per kWh in 2024, from FERC Form 1
    Table 8.4. Average Power Plant Operating Expenses for Major U.S. Investor-Owned Electric Utilities, 2014 through 2024 (Mills per Kilowatthour)
    backsC51
  25. S25primarycompany release2026-11-02
    the quarter by segment, adjusted EBITDA, tightened 2026 guidance, the preliminary 2027 outlook and the balance sheet
    backsC03C12C23C38
  26. S26primarycompany filing2026-11-02
    backlog by segment, the PCG acquisition of 1 July 2026 and the medical sale agreement of 31 July 2026
    backsC03C04
  27. S27primarytranscript2026-11-02
    BWXT Q3 2026 earnings call transcript (FMP), held 2026-11-02
    the timing of the first new-build order, the Government Operations margin drivers, the 2027 outlook, and the gate on large-reactor decisions
    I said at the beginning of this year that I expected us to have new orders for U.S. reactor plant builds in -- by the end of this year. And I still think that's a possibility for us, but certainly no later than about the first half of the next year.
    backsC29
  28. S28primarycompany filing2026-11-09
    trailing revenue, operating profit, stock pay, tax, debt, cash and the diluted share count
    backsC57
  29. S29secondaryvendor data2026-11-09
    the analysts' average revenue and operating profit for the next three fiscal years, and the close
    backsC56C57
Rendered from content/BWXT/thesis.json · thesis reviewed 2026-11-02. This page explains a company; it does not say what to pay, when to buy or how much.